Rapid acceleration of diagnostics (radx) ATP program - project #7338

Ended Definitive Contract Awarded Last action

Contract number
75N92020C00024
Awardee
Awarding agency
Obligated
$14,265,625

Award facts

Contract value 69% obligated
  • $14,265,624.53 Current, with exercised options
  • $20,749,999.53 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
National Institute of Biomedical Imaging and Bioenginering National Institutes of Health, Department of Health and Human Services
NAICS code
621511 Medical Laboratories
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Brentwood, TN 37027, USA
Legislative mandates
National interest action
Coronavirus COVID-19

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00004 $0
Other Administrative Action P00003 $0
Other Administrative Action P00002 $0
Definitize Letter Contract P00001 $7,265,625
Original award $7,000,000

About this award

The Department of Health and Human Services National Institutes of Health National Institute of Biomedical Imaging and Bioengineering awarded a $20.7 million firm fixed price definitive contract to Associated Pathologists, LLC (doing business as Pathgroup) for the Rapid Acceleration of Diagnostics (RADX) ATP Program - Project #7338. The contract is being funded under the Coronavirus COVID-19 national interest action code and will support RADX's goal of accelerating the development, commercialization, and implementation of COVID-19 testing technologies, devices, and infrastructure. Performance will take place in Brentwood, Tennessee over a two year period concluding December 2021. No set aside designation was specified.

Quick answers

Who was awarded contract 75N92020C00024?

75N92020C00024 was awarded to Associated Pathologists, LLC by National Heart Lung and Blood Institute (National Institutes of Health) on September 2, 2020.

How much is contract 75N92020C00024 worth?

The government has obligated $14,265,625 on 75N92020C00024. Its potential value, with all options, is $20,750,000.

Which agency awarded contract 75N92020C00024?

National Heart Lung and Blood Institute (National Institutes of Health) awarded 75N92020C00024, with funding from National Institute of Biomedical Imaging and Bioenginering (National Institutes of Health).

Was contract 75N92020C00024 competed?

The extent of competition for 75N92020C00024 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award